# Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke

> **NCT07290751** · PHASE4 · RECRUITING · sponsor: **Beijing Anzhen Hospital** · enrollment: 976 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Tirofiban
- **OTHER:** Placebo (0.9% normal saline)

## Key facts

- **NCT ID:** NCT07290751
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-11
- **Primary completion:** 2026-10-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 976 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07290751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07290751, "Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07290751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*